Bluejay Therapeutics logo

Bluejay Therapeutics Funding & Investors

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases. The company’s first target indication is chronic Hepatitis B, which remains a worldwide prevalent disease with urgent unmet medical need. Bluejay is advancing two innovative appro... Read more

bluejaytx.com

Total Amount Raised: $242,239,984

Bluejay Therapeutics Funding Rounds

  • Series C

    $182,000,000

    Series C Investors

    Frazier Life Sciences
    Wellington Management
    HBM Healthcare Investments
    Unicorn Capital Partners
    Octagon Capital Advisors
    Novo Holdings
    RiverVest Venture Management
    T. Rowe Price
    Ra Capital Management
    Arkin Bio Ventures
  • Series B

    $41,000,000

    Series B Investors

    Arkin Bio Ventures
    Yonjin Venture
    RiverVest Venture Management
    Octagon Capital Advisors
    Synergenics
  • Series Unknown

    $19,239,990

Funding info provided by Diffbot.